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The formation of amyloid-like fibrils is characteristic of vari-
ous diseases, but the underlyingmechanism and the factors that
determine whether, when, and how proteins form amyloid,
remain uncertain. Certain mechanisms have been proposed
based on the three-dimensional or runaway domain swapping,
inspired by the fact that some proteins show an apparent corre-
lationbetween the ability to formdomain-swappeddimers anda
tendency to form fibrillar aggregates. Intramolecular -sheet
contacts present in the monomeric state could constitute inter-
molecular -sheets in the dimeric and fibrillar states. One
example is an amyloid-forming mutant of the immunoglobulin
binding domain B1 of streptococcal protein G, which in its
native conformation consists of a four-stranded-sheet andone
-helix. Under native conditions this mutant adopts a domain-
swapped dimer, and it also forms amyloid-like fibrils, seemingly
in correlation to its domain-swapping ability.We employmagic
angle spinning solid-state NMR and other methods to examine
key structural features of these fibrils.Our results reveal a highly
rigid fibril structure that lacks mobile domains and indicate a
parallel in-register-sheet structure and a general loss of native
conformation within the mature fibrils. This observation con-
trasts with predictions that native structure, and in particular
intermolecular -strand interactions seen in the dimeric state,
may be preserved in “domain-swapping” fibrils. We discuss
these observations in light of recent work on related amyloid-
forming proteins that have been argued to follow similar mech-
anisms and how this may have implications for the role of
domain-swapping propensities for amyloid formation.
Amyloid fibril formation is characteristic of a variety of
human disorders, including Huntington and Alzheimer dis-
eases (1, 2). In amyloid-related diseases, one or more proteins
are found in fibrillar aggregates, in a non-native, highly-sheet-
rich conformation. Depending on the disease context, the pro-
pensity for amyloid formation may be traced to mutations and
cleavage events, combined with poorly understood external
triggers.Many proteins can also bemade to formamyloid fibrils
in vitro. Intriguingly, there are many accounts of proteins that
form amyloid-like fibrils that are not associated with patholo-
gies (2). Whether disease-related or not, amyloid fibrils share
key biochemical and biophysical characteristics, suggesting
common structural features. Understanding the fibril forma-
tion pathway is of interest not only as theremay be a correlation
between disease onset and protein aggregation, but also
because transient oligomeric precursors may act as toxic spe-
cies. However, a lack of high resolution structures of most
fibrils and their precursors limits our knowledge of the mecha-
nism of formation.
One seemingly common structural motif for amyloid fibrils
is an in-register parallel (IP)3 assembly into pleated -sheets,
stabilized by backbone-to-backbone hydrogen bonding, com-
bined with favorable side-chain interactions (e.g. Asn or Gln
ladders or hydrophobic clustering) (3–5). Such “serpentine”
models have been invoked for various proteins and explain
some intriguing features of amyloid formation, such as insensi-
tivity to sequence scrambling (6). One consequence of serpen-
tine assemblies is the loss of the hydrogen bonding interactions
characteristic of the native tertiary structure.
In seeming contrast, there are cases where a persistence of
the native structure has been reported, even upon amyloid for-
mation. Such observations may not be contradictory, if the
native conformations occur in non-amyloidogenic domains
that remain attached to the amyloid itself (7, 8). However,
native interactions couldwell be preservedwithin the fibril core
for proteins that natively contain-sheets, as proposed for2m
and transthyretin, for instance (9, 10). Similar ideas form the
basis for proposed mechanisms of three-dimensional domain
swapping or runaway domain swapping (11, 12). The basic
principle here is that structural motifs that are present in
domain-swapped dimers can also accommodate more exten-
sive oligomerization leading to, e.g., amyloid formation. These
models have gained support from the fact that various amy-
loidogenic proteins are able to form domain-swapped dimers.
The amyloid-forming protein cystatin C, which is the cause of a
cerebral amyloidosis, is a key example. Certain mutants form
amyloid fibrils and also undergo domain swapping, and inhibi-
tion of domain swapping also affects fibril formation (13–17).
Domain swapping has also been proposed as an oligomeriza-
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tion mechanism for transthyretin (18), 2m (19–21), and the
prion protein (22, 23), although arguably with less direct evi-
dence to support these cases. More data are available on non-
disease-related proteins where domain swapping and amyloid
formation seem to correlate (24–29). In one case a domain-
swapped oligomeric species even shows toxicity, paralleling
amyloid-related oligomers (29).
In such cases, -sheet elements of the native protein struc-
ture are preserved in the domain-swapped dimer: native
strand-strand hydrogen bonding that is intramolecular in the
monomer becomes intermolecular in the dimer. Partial unfold-
ing and structural rearrangements are needed to attain a
dimeric structure, and it is proposed that similar re-arrange-
ments can open up pathways to more extensive oligomeriza-
tion.Hinge loop regions have different conformations inmono-
meric and domain-swapped structures and may facilitate
continued oligomerization (20). Although there are various
reports of apparent correlations between domain swapping and
amyloid formation, there is a lack of structural data that
unequivocally demonstrate the preservation of native structure
within the mature fibril, a key feature of its most basic
principles.
Here, we use MAS ssNMR to examine fibrils formed by one
of the proteins that displays such a correlated tendency for
domain swapping and amyloid formation, a mutant of the GB1
protein. GB1 itself has served as amodel for protein folding and
stability studies, and a number of mutants form amyloid fibrils
(31–34). One of these is a domain-swapping mutant (dsGB1)4
with mutations that destabilize the hydrophobic core and the
native -helix (26, 27). Relative to the highly stable and well
studied T2Q version (35) of GB1 (henceforth referred to simply
as GB1), the mutations are L5V, F30V, Y33F, and A34F (26).
These mutations destabilize the monomeric state and instead
favor a domain-swapped dimer (Fig. 1), which is less stable than
monomeric T2Q-GB1. In analogy to studies on other domain-
swapping amyloid-formers, a combination of solution NMR,
mutational studies, and disulfide bond formation suggests a
correlation between amyloid formation and domain-swapping
ability (26). Accordingly, it was suggested that native-like con-
tacts may be conserved in the fibrillar state, as predicted by
certain runaway domain-swapping models.
MAS ssNMR provides direct molecular insight into the
structure of amyloid fibrils (36), allowing us to obtain key struc-
tural information on themature dsGB1 fibrils. Combined with
hydrogen-deuterium exchange experiments, it reveals a
highly rigid and largely -sheet conformation. The ssNMR
also indicates intermolecular same-to-same interactions
consistent with a parallel -sheet geometry, as commonly
seen in other amyloid-forming proteins. Our data indicate a
loss of key interactions that characterize the monomeric and
domain-swapped dimer conformations, especially loss of
both the native helical segment and specific strand-strand
interactions of the native -sheet assembly. We conclude
with a discussion of implications for domain-swapping
mechanisms invoked for amyloid formation for this and
other amyloidogenic proteins.
EXPERIMENTAL PROCEDURES
Protein Expression andPurification—ThedsGB1proteinwas
expressed, isotopically labeled, and purified using standard
methods (26). Briefly, plasmid pET11A coding for dsGB1 was a
gift from Angela Gronenborn (University of Pittsburgh). Uni-
formly and selectively 13C- and/or 15N-labeled protein was
obtained by expression in Escherichia coli HMS174 (DE3),
using M9 minimal medium and isotopically labeled materials
from Cambridge Isotope Laboratories (Andover, MA) and Iso-
tec (Sigma-Aldrich). 13CO Tyr-labeled sample was prepared as
previously described (37).
Fibril Sample Preparation—Protein in 50 mM sodium phos-
phate buffer (pH 5.5) was concentrated to0.7 mM, then cen-
trifuged at 100,000  g for 1 h (Optima ultracentrifuge, Beck-
manCoulter) to eliminate pre-existing aggregates, giving a final
concentration of 0.5–0.6 mM. Fibrils are formed over several
days, under agitation at 58 °C and 600 rpm (26) and then iso-
lated by centrifugation. ForMAS ssNMR experiments, 8–9mg
of pelleted fibrillized protein was packed into a 3.2-mm MAS
rotor (Bruker BioSpin, Billerica, MA) using a customized sam-
ple packing tool under 130,000 g centrifugation.
Electron Microscopy—An aliquot of 5 l from the aggrega-
tion mixture was placed on freshly glow-discharged, carbon-
coated, 400-mesh-size copper grids and adsorbed for 2 min.
Grids were washed with deionized water and then stained with
freshly filtered 1% (w/v) uranyl acetate for 2–15 s. Grids were
imaged in the Structural Biology Department’s EM facility on a
Tecnai T12microscope (FEI) operating at 120 kV and 30,000
magnification and equipped with an UltraScan 1000 charge-
coupled device camera (Gatan) with post-column magnifica-
tion of 1.4.
H/D Exchange Measurements—Sequestration of amide pro-
tons within the fibrils was examined via hydrogen-deuterium
(H/D) exchange experiments monitored by solution NMR (9,
38). Amyloid fibrils of 15N-labeled dsGB1 were centrifuged at4 Previously also referred to as the HS#124F26A mutant.
FIGURE 1. A, sequence alignment between T2Q-GB1 and dsGB1. B and C,
schematic illustration of dsGB1 native and domain-swapped structures. The
dashed box highlights the preservation of a monomer-like fold in domain-
swapped dimeric dsGB1. Residues highlighted in yellow indicate mutation
sites from T2Q-GB1. Upon fibril formation, mutation of T44 (green) to Cys
permits formationof an intermolecular disulfidebond. This indicates an inter-
monomer proximity of residue 44 in the fibrils as also found in the domain-
swapped dimer.
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5000  g for 10 min, washed with 50 mM sodium phosphate
buffer (pH 5.5), and lyophilized. 0.8mg of the fibril wasweighed
and resuspended in deuterated buffer (50 mM sodium phos-
phate and D2O, pD 5.5). At the indicated time points, aliquots
were centrifuged and frozen in liquid nitrogen to quench
exchange. The frozen samples were dissolved in perdeuterated
dimethyl sulfoxide (d6-DMSO) containing 5% D2O and 0.01%
d2-dichloroacetic acid. After dissolution, the solution was
immediately transferred into an NMR tube, and the heteronu-
clear single quantum coherence spectrum was recorded at
25°C. ssNMR experiments were recorded on 18.8-T (800-MHz
1H frequency), 16.4-T (700MHz), and 14.1-T (600MHz) spec-
trometers (Bruker BioSpin) equipped with cryoprobes. More
details can be found in the supplemental materials.
ssNMR Spectroscopy—MAS ssNMR experiments were con-
ducted using 3.2-mmHCNEfreeMASprobes (Bruker BioSpin)
at static magnetic fields of 14.1 and 18.8 T (1H frequencies of
600 and 800MHz). Spinning rateswere typically 13 kHz (at 14.1
T) or 17 kHz (at 18.8 T) unless stated otherwise, with sample
cooling at 267 K. Standard two-dimensional and three-dimen-
sionalMAS ssNMR assignment experiments were employed to
assign the resonances, mostly via NCOCX and NCACX exper-
iments, along with two-dimensional 13C-13C spectra obtained
with dipolar-assisted rotational resonance (39) and phase-al-
ternated recoupling irradiation scheme (PARIS) (40) 13C-13C
mixing. A series of two-dimensional 13C-13CNMR spectrawith
23-, 54-, and 100-ms PARIS mixing were used to probe longer
distance 13C-13C contacts (at 17-kHz MAS and 800-MHz 1H
frequencies). To probe the inter-strand register, PITHIRDS-
CT measurements (41, 42) were carried out using fibrils pre-
pared from Tyr-1-13CO-labeled dsGB1 at 600 MHz (1H fre-
quency) and anMAS frequency of 20 kHz, with up to 38.4ms of
total dipolar recoupling. Two fibril samples were prepared: one
entirely from Tyr-1-13CO labeled protein and the other from
the same labeled protein diluted 1:2 with unlabeled protein.
PITHIRDS-CT reference dephasing curves were calculated
with the SPINEVOLUTION program (43), assuming a linear
chain of five equally spaced 13C labels consistent with an IP
-sheet. More details can be found in the supplemental
materials.
RESULTS
Fibril Preparation and Characterization—In line with previ-
ous reports (26), we observed fibril formation by dsGB1 under
agitation at 58 °C. After an initial lag phase, an increase in thio-
flavin T binding was observed that completed within several
days. During early stages, alongside fibrils, circular assemblies
could be seen by EM (Fig. 2A) that appear similar to oligomeric
species previously reported for other amyloids, such as A (44).
Over time, these transient species disappeared yielding the
mature fibrils (Fig. 2B).
MAS ssNMR Chemical Shifts and Secondary Structure—
MAS ssNMR was used to study mature fibrils formed from
uniformly and selectively labeled dsGB1. Assignments were
obtained for most of the residues, with some exceptions due to
signal overlap (see supplemental Table S2 and Fig. 3). The 13C
line width in homonuclear spectra was typically1 ppm, indi-
FIGURE 2. Negative stain transmission electron microscopy images of
dsGB1 during the aggregation process, showing circular assemblies as
well as fibrils (A), andofmaturedsGB1fibrilshavingahomogeneousand
periodically twistedmorphology (B). Scale bars indicate 50 nm.
FIGURE 3. MAS ssNMR spectra on 13C,15N-labeled dsGB1 fibrils. A, 13C-13C two-dimensional PARIS spectrum with 23-ms mixing time; B, NCACX; and C,
NCOCX two-dimensional spectra with 5-ms 13C-13C dipolar-assisted rotational resonancemixing. These datawere acquired at 800MHz (1H frequency), 17 kHz
MAS rate, and 267 K.
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cating a relatively homogeneous and well ordered structure. A
number of sites were found to display two sets of peaks, in
particular residues Asn8 and Gly9, the segment Asp22–Ala26,
Gly38 andVal39, andAla48 (e.g. supplemental Fig. S2). Such peak
doubling is indicative of variations in the local environment or
structure. In some cases it appeared due to partial deamidation
of specific Asn side chains (also seen in solution), but elsewhere
it may be explained by increased conformational freedom for
residues in less restricted loop regions (e.g. residues
Asp22–Ala26).
The assigned 13C, 13C, 13CO, and 15N shifts were used for
CSI (45) and TALOS analysis (46), which indicate a predom-
inance of -sheet structure (Fig. 4). The lack of contiguous res-
idues with helix-typical chemical shifts indicates that the native
-helix is lost in the fibrils and instead converted into -sheet
structure. These observations also hold true for the secondary
conformations detected within the fibrils. More generally,
comparison of the fibril chemical shifts to those of the native
structure, as reported for dsGB1 by solution NMR (27) or
microcrystalline GB1 (47), indicates a large difference in most
of the shifts (see supplemental Fig. S1). These differences
exceed those expected for experimental differences between
solution and ssNMR, for instance due to intermolecular inter-
actions (48). Rather, the chemical shift differences indicate sub-
stantial structural differences that are not limited to the hinge
loops or swapped domains.
Rigidity and Solvent Exposure—Exposure of the fibrils to
D2O allows exchange of mobile sites, which can reveal the non-
exchanging fibril core, as it is expected to be highly stable under
aqueous conditions. To detect exchangeability in a residue-spe-
cific fashion, we quenched the exchange, dissolved the fibrils in
high concentrations of DMSO (where exchange is suppressed),
and performed solution NMR to detect residual protons (9, 38,
49). 1H-15Nheteronuclear single quantumcoherence spectra of
dsGB1 dissolved in 95%DMSO-d6/5%H2O at pH 5.5 and room
temperature reveal backbone HN chemical shifts consistent
with a denatured state (supplemental Fig. S3). Assignments
obtained in U-13C,15N-labeled reference samples were
employed to site-specifically identify the exchanged sites. Sim-
ilar to previous reports (9, 38), certain residues are found to
undergo rapid H/D exchange in the DMSO solvent system, pre-
ventinga robust analysis of their exchange in the fibrils.These sites
are mostly charged residues and their neighbors, consistent with
previous observations andmechanistic discussions (38, 50). From
the remaining sites,wegenerated theH/Dexchangeprofile shown
inFig. 5, showing theexchangeafter24h.The fact thatmanypeaks
throughout the sequence had a residual intensity of50% implies
that dsGB1 fibrils are rigid and highly protected. Even after expo-
sure of fibrils to D2O for 4 weeks many amides were still highly
protonated (supplemental Fig. S3D). Remarkably, the N-terminal
segment Tyr3–Val5 and the very C-terminal segment Phe52–
Thr55 showedparticularly high levels of protection. In general, the
exchange of all observable sites was relatively low and no dynamic
loops or termini are apparent.
Tertiary Structure of the Fibrils—A key feature of domain-
swapped dimers is that some native hydrogen bonding patterns
are preserved, but in an inter- rather than intramolecular fash-
ion.We performed selectedMAS ssNMRexperiments to probe
intermolecular interactions in the fibrils. The PITHIRDS-CT
experiment is designed for the detection of intermolecular con-
tacts in IP fibrils, prepared with site-specific carbonyl and/or
methyl group 13C-labeling (41). Fibrils were prepared from
dsGB1, which was 13CO-labeled in both tyrosines (Tyr3 and
Tyr45). After correction for natural abundance background sig-
FIGURE 4. Secondary chemical shift analysis of the fibrils. The primary sequence and native conformation are indicated at the top. The next row shows
(13C)-(13C), the difference between experimental 13C-13C ssNMR chemical shifts and corresponding “random-coil” values. Residues with missing
assignments are indicatedwith asterisks. Significantly positive values indicate-helical structure (red), and negative values indicate-strands (blue). Chemical
shift indexing (CSI) or the TALOSprogramalso indicate high-sheet content (45, 46). Although TALOS appears to suggest two long-strands, it is possible
that there are additional loop regions not identified by this algorithm.
FIGURE 5. Relative peak intensities in the 24-h H/D exchange spectrum
(see supplemental Fig. S3C) plotted against residue number. Peak inten-
sitieswerenormalized to the reference spectrum (supplemental Fig. S3B), but
incompletely separated peaks () and peaks highly influenced by fast
exchange in DMSO (*) are omitted.
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nals, the signal decay indicatedadistanceof close to6Åbetween
neighboring labeledcarbonyl sites (Fig. 6).These interactionswere
unequivocally intermolecular, as amyloid fibrils formed from co-
fibrillization of labeled and unlabeled protein in a 1:2 ratio showed
a dramatic decrease in the extent of dephasing (Fig. 6). Our data
curves and fit results were highly similar to previous reports on
other IP protein fibrils (5, 41, 51, 52).
To explore the tertiary structure of the dsGB1 fibrils, we also
examined a series of 13C-13C experiments applied to both fully
labeled and isotopically diluted samples. These experiments
employed the PARISmixing scheme (40, 53), a 13C-13C transfer
experiment that permits cross-peaks up to 4.8 Å to be easily
observed, with distances up to 5.7 Å reported (53). Long dis-
tance intermolecular C-C contacts can be indicative of the
supramolecular alignment (54). Intramolecular sequential Ci-
Ci1 contacts are expected to be3.8 Å. Peptidemodel struc-
tures (55) suggest that, in an IP -sheet, the intermolecular
Ci-Ci contacts are4.9 Å, whereas Ci-Ci1 distances are
6 Å. In anti-parallel -sheets (55), the C-C distances were
4.7–5.1 Å, but in this case intermolecular contacts would not
consistently involve the same or neighboring residues in the
primary sequence, giving Ci-Cj contacts with j  i (1).
Thus, long mixing PARIS experiments should reveal primarily
sequential C-C contacts for an IP -sheet, but, for an anti-
parallel -sheet, other Ci-Cj contacts are expected (that dif-
fer from local contacts seen for shorter mixing times).
13C-13C spectra of dsGB1 fibrils with mixing times of 23 and
100 ms are shown in Fig. 3A and Fig. 7. 30 out of 55 sequential
C-C cross-peaks were identified at 100-ms mixing time,
along with7 peaks that are too close to the diagonal or over-
lapped with intra-residue contacts. Fibrils prepared from a 1:1
ratio of 15N-only- and 13C-only-labeled protein give very simi-
lar spectra with mostly the same cross-peaks, although they are
limited by the reduced signal to noise andwith some changes in
the relative peak intensities. The lack of “additional” peaks in
the fully labeled sample indicates that intermolecular contacts
are analogous to the intramolecularC-C contacts and is con-
sistent only with a parallel -sheet geometry in which each res-
idue in the fibril is in-register and eachmonomer is in nearly the
same local conformation (54).
FIGURE 6. 13C PITHIRDS-CT data for Tyr-1-13CO-labeled dsGB1 fibrils,
indicating a close intermolecular proximity of the Tyr carbonyls, consis-
tentwithan IP-sheet structureand similar toprevious studiesonother
amyloid fibrils. Fully labeled fibrils show significant dephasing, which is
largely eliminated in fibrils containing a 1:2mixture of labeled and unlabeled
protein (dilute). Simulated dephasing curves are shown that correspond to
interatomic distances from 5.0 to 7.0 Å in 0.5-Å increments. Measurements
were done at 14.1 T, 20-kHz MAS, and 267 K.
FIGURE7.Sectionof 13C-13C two-dimensionalPARIS spectrawith100-msmixing time, showingassignmentsof sequential C-C cross-peaks forboth
uniformly labeled (A) and 1:1 isotopically diluted (B) dsGB1 fibrils. The observed C-C peaks in the undiluted sample largely map onto those observed
in the diluted sample (aside from intensity changes) and reflect local (i3 i 1) interactions. Such observations indicate an IP conformation (54).
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DISCUSSION
We have characterized key structural features of the fibrils
formed by the domain-swapping model protein dsGB1, which
has served as an example of how domain-swapping propensity
may result in an ability to form amyloid-like fibrils. Inmodels of
three-dimensional or runaway domain swapping in amyloid
formation, it is often proposed that the resulting fibrils would
incorporate structural features that reflect strand-strand inter-
actions that are present in the domain-swapped intermonomer
interface. However, our results point to a loss of the native
structure. Large differences in chemical shift are seen through-
out the primary sequence. Secondary structure analysis by
ssNMR indicates a loss of the native -helix. Rather, ssNMR
and H/D exchange point to a highly rigid amyloid core that
spans the entire protein. Furthermore, the ssNMR-based detec-
tion of intermolecular contacts shows that these fibrils adopt an
IP conformation, similar to many other amyloid-like fibrils (3,
5). Such “serpentine” amyloid structures are often character-
ized by short -strands with intervening loop regions. Several
data suggest at least one loop region near residues 22–26, where
we see local non- structure as well as a propensity formultiple
conformations as reflected in doubled peak assignments.
The presence or absence of other loops remains uncertain,
because indications of their presence are ambiguous. Nonethe-
less, the possibility of more than two -strand segments cannot
be excluded. Remarkably, the loop regions and termini appear
to be highly protected from H/D exchange, suggesting a very
rigid and compact amyloid structure that lacks the flexible seg-
ments outside the amyloid core seen in many other amyloid
fibrils.
Previous experiments on this particular dsGB1 mutant
reported a correlation between the ability to undergo domain
swapping into a dimeric form and the propensity to aggregate
into amyloid-like fibrils (26). As the dimeric form was found to
resemble the native monomeric conformation (Fig. 1) and var-
ious experimental data suggested similar interactions in the
aggregated state, it was proposed that aspects of the native
-sheet structure persisted in the fibrils. These data combined
solution NMR and the examination of disulfide formation by
cysteine mutants, methods also used on other domain-swap-
ping amyloidogenic proteins. T44C mutants (26) displayed
intermolecular disulfide bond formation consistent with the
anti-parallel interface seen in the domain-swapped dimer, sup-
porting a structural model for the fibrils that incorporated
native-like -sheet interactions. Our data are consistent with
these experimental data observed before, although we suggest
an alternate explanation. In particular, the IP fibril assembly
that we observed would define a stacked alignment of the Cys
residues in neighboring strands, close enough to allow an inter-
molecular disulfide bond.
Serpentine fibril structures consisting of IP stacks of pleated
-strands appear to be increasingly common, as more detailed
structural data is gained on proteins within amyloid-like fibrils
(4). For instance, an earlier x-ray diffraction study on amyloid
fibrils formed by different amyloid-forming mutants of GB1
indicated such a conformation for those GB1 fibrils (31). The
authors described a twisted structure featuring IP-stacked
slabs, each containing four tightly packed -strands that are
part of a single protein. It remained unclear what the fate of the
native helix was, how the native -strands map onto the amy-
loid core strands, and to what degree there were unstructured
loops or termini. Thus, the extent of correspondence between
the amyloid conformations of these different mutants and the
dsGB1 variant remains uncertain. Note that it is well known
that polymorphic fibrils can be obtained from a single protein
(56, 57), let alone from amyloidogenic proteins with different
primary sequences.
Mechanism of dsGB1 Aggregation—The structural states of
themonomer-dimer equilibriumof dsGB1 and relatedmutants
have been well characterized by solution NMR (26, 27, 58, 59).
Compared with the domain-swapped dimer, the monomer is
substantially more flexible, in particular near the N terminus
(59). The more stable dimer avoids structural clashes in the
hydrophobic core that prevent a stable monomeric conforma-
tion. Instead, the monomeric form is more like a molten glob-
ular structure that maintains the -helix/C-terminal-hairpin
core but lacks interactions that would stabilize the N-terminal
-hairpin (59). Thus, the spontaneous monomer-dimer refold-
ing involves a preservation of certain secondary and tertiary
structure interactions (e.g. conserving the highly stable 3-4
hairpin). Dimerization seems to be facilitated by antiparallel
interactions of pre-existing -hairpins, with very specific side-
chain reorientations involved in the stabilization of the result-
ing structure (58).
In contrast, amyloid formation by dsGB1 requires both ele-
vated temperatures and agitation, not unlike other amyloido-
genic proteins. Agitation enhances amyloid formation through
mechanisms that may include enhanced seeding, structural
deformation, as well as modulation of local protein concentra-
tions (60, 61). The need for elevated temperatures suggests that
further destabilization of the structure is needed to initiate
amyloid formation. Is this due to the need for sufficient disrup-
tion of the residual stable structure that is present in themono-
mers at lower temperatures? Amyloid formation may initiate
with the coming together of these lesswell structured (although
not necessarily fully unfolded) proteins, possibly mediated by
hydrophobic interactions of exposed core residues. Note that
the dsGB1 mutations (in particular the mutation A34F) affect
the orientation and integrity of the -helix and its interactions
with the -strands and cause an extension of the neighboring
loop region, thus opening up the hydrophobic core (58). It
could then be that resulting oligomeric species permit extended
structural elements (e.g. unstructured loop regions or isolated
-strands) to form a core of parallel -sheets, which nucleate
fibril growth. Once initiated, nucleation and seeded growth
could further destabilize residual native secondary structure
present in the oligomers to yield the completely non-native
fibrils that we observed. Naturally, the detailed aggregation
process, as well as the nature of on-pathway oligomers, remains
ill-defined and speculative, reminiscent of the oligomeric pre-
cursors of many other amyloid-forming proteins.
Domain Swapping in Other Amyloid-forming Proteins—
Clearly, the dsGB1 protein is just a single example where a
correlation between domain-swapping and amyloid formation
has been reported. So the question arises whether our observa-
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tion, that this protein’s mature fibrils are not native-like, is an
isolated case that does not hold true for other domain-swap-
ping proteins. Here, it is worth noting that recent studies have
suggested similar features in other proteins. For 2m and prion
proteins, domain-swapped dimers have been observed (19, 20),
but for both proteins ssNMR and ESR studies on fibrils have
indicated an IP sheet structure and a loss of the native confor-
mation (51, 62–65). Thus, at least in a number of cases, similar
observations have beenmade, whenmature fibrils were studied
directly.
Role of Domain Swapping in Amyloid Formation—Even if
native structure may not be preserved in the fibrils, there
remain seemingly compelling examples of a correlation
between the ability to form domain-swapped dimers and the
propensity to form amyloid. A somewhat trivial explanation
would be that those proteins indeed form amyloid via a
domain-swapping mechanism and that simply the “right” pro-
teins have not been studied yet. Or, itmay even be that a protein
like dsGB1 forms polymorphic fibrils, some of which do indeed
have a fibril structure that is native-like and was formed via
domain swapping.
There may also be a true correlation between domain swap-
ping and fibril formation that affects steps occurring along the
fibril formation pathway without resulting in native-like struc-
ture in the fibrils. It is important to realize that our experiments
probe the final mature fibrillar state, which will be predomi-
nantly assembled post-nucleation via seeded growth. Although
it is generally thought that this templated mechanism would
reflect the structure of the original seed, this may not be uni-
versally true. In other words, even if the earliest aggregates may
form via domain swapping, the subsequent fibril extensionmay
follow a distinctly different mechanism and result in the non-
native structure that we observed. Similarly, it also is possible
that domain swapping occurs prior to nucleation, resulting in
the assembly of native-like but transient oligomeric aggregates.
Note that various oligomeric assemblies of amyloidogenic pro-
teins feature-helical or native-like structures (66, 67) that typ-
ically, but not always (68), are lost during fibril maturation.
Another manner by which the propensity for domain swap-
ping may correlate to amyloidogenicity is in the earliest stages,
prior to oligomer formation. It could simply be that domain
swapping necessitates destabilization of the monomeric (or
native) structure and that destabilization of the native confor-
mation is also a prerequisite for amyloid formation. Proteins are
dynamic in solution, andmultiple conformations are populated
at the same time, but the majority is usually in the native struc-
ture, as it has the lowest energy. Aggregation-prone conforma-
tions may be present, but only at a low population, resulting in
a long lag time of aggregation. Exposure to denaturing condi-
tions, but also mutations, can destabilize the native structure,
increase the population of partially unfolded conformations,
and thus encourage aggregation. For GB1 and its variants, the
highly stable T2Q-GB1 variant (35) has not been reported to
form fibril, but destabilization of the GB1 fold allows formation
of amyloid-like fibrils under appropriate conditions, in correla-
tion to the extent of destabilization (26, 32–34). Nonetheless, it
is unclear that destabilization is the only factor, because this
may suggest that all proteins would be prone and able to form
amyloid fibrils under appropriate conditions. There are exam-
ples, for instance among SH3 domains, where stability alone
does not explain differences in amyloidogenicity (30). Similarly,
a closely similar GB1mutant with a melting temperature lower
than dsGB1, but lacking its domain-swapping propensity, fails
to form fibrils despite a reduced stability (26, 59). Rather, spe-
cific conformations may exist that are crucial for the protein to
form amyloid fibrils, and destabilized proteins may not always
have access to appropriate conformations. Domain swapping
may thus fulfill one of the requirements for amyloid formation
by destabilizing the native structure but also favor structural
propensities that help generate on-pathway assemblies and
structures that facilitate amyloid formation. Although this is
thus far completely hypothetical, a possibly related observation
is that loop regions appear to be important for domain swap-
ping (11) but also for amyloid formation (e.g. in defining the
fibril-forming ability of different SH3 domains) (30).
Summary—We have shown the loss of the native conforma-
tion upon amyloid formation by the domain-swapping model
protein dsGB1, in contrast with certain models of domain
swapping-induced amyloid formation. The protein undergoes a
complete structural rearrangement to form the IP -sheet,
more reminiscent of the increasingly common “serpentine”
amyloid conformations than structural models commonly pro-
posed in the context of the runaway domain swapping-related
amyloid formation. How applicable these observations are to
other domain-swapping proteins remains to be seen, but they
appear to echo a number of other studies and at the least raise
questions about the precise role of domain swapping and the
structural requirements for the conversion of native to amy-
loid-like conformations.
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